TrialClinical and experimental nephrology2025
Efficacy and safety of patiromer for hyperkalemia: a randomized, placebo-controlled phase 3 study.
Naoki Kashihara et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this paperpooled itcites it